Regeneron Pharmaceuticals
REGN
REGN
1,300 hedge funds and large institutions have $89.1B invested in Regeneron Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 479 increasing their positions, 448 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,300
Holders Change
+37
Holders Change %
+2.93%
% of All Funds
18.85%
Holding in Top 10
25
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
145
Increased
479
Reduced
448
Closed
94
Calls
$971M
Puts
$1.63B
Net Calls
-$660M
Net Calls Change
+$17M
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
$1.63B |
| 2 |
JPMorgan Chase & Co
New York
|
$7.44B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$10.4B |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
$462M |
| 5 |
Invesco
Atlanta,
Georgia
|
$949M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$1.29B |
| 2 |
Capital World Investors
Los Angeles,
California
|
$4.48B |
| 3 |
Holocene Advisors
New York
|
$78.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$75.6M |
| 5 |
D.E. Shaw & Co
New York
|
$222M |